rss
J Neurol Neurosurg Psychiatry 77:665-667 doi:10.1136/jnnp.2005.085019
  • Short report

Prevalence of the LRRK2 G2019S mutation in a UK community based idiopathic Parkinson’s disease cohort

  1. C H Williams-Gray1,
  2. A Goris2,3,
  3. T Foltynie1,
  4. J Brown1,
  5. M Maranian2,
  6. A Walton2,
  7. D A S Compston2,
  8. S J Sawcer2,
  9. R A Barker1
  1. 1Cambridge Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, UK
  2. 2Neurology Unit, Department of Clinical Neurosciences, University of Cambridge, UK
  3. 3Laboratory for Clinical and Experimental Neurology, Katholieke Universiteit Leuven, Belgium
  1. Correspondence to:
 Dr C Williams-Gray
 Cambridge Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Forvie Site, Robinson Way, Cambridge CB2 2PY, UK; chm27{at}cam.ac.uk
  • Received 25 November 2005
  • Accepted 22 December 2005
  • Revised 19 December 2005

Abstract

The LRRK2 G2019S mutation is the commonest genetic cause of Parkinson’s disease (PD) identified to date, although estimates of its prevalence in idiopathic disease vary considerably. Our objectives were to determine G2019S mutation frequency in an unselected, community based cohort of idiopathic PD cases from the UK and to describe phenotypic characteristics among carriers. The mutation was present in two of 519 cases (0.4%) and none of 887 control individuals. The true prevalence of the mutation in idiopathic disease, its penetrance, and the phenotypic heterogeneity of associated cases have important implications for genetic screening in the clinical field.

Footnotes

  • Competing interests: none declared

Podcasts
Visit the full archive of podcasts for JNNP here >>

Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of JNNP.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article